dabigatran in the treatment of warfarin-induced skin necrosis: a new hope
Clicks: 194
ID: 240932
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.2
/100
194 views
50 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #7 of 23 articles by views in diogenes
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Warfarin-induced skin necrosis is an infrequent and well-recognized complication of warfarin treatment. The incidence was estimated between 0.01% and 0.1% whereas a paradoxal prothrombotic state that arises from warfarin therapy seems to be responsible for this life-threatening disease. To the best of our knowledge we present the first case of an old woman diagnosed with warfarin-induced skin necrosis, in whom novel oral anticoagulants and extensive surgical debridement were combined safely with excellent results.
| Reference Key |
bakoyiannis2016casedabigatran
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Christos Bakoyiannis;Georgios Karaolanis;Nikolaos Patelis;Anastasios Maskanakis;Georgios Tsaples;Christos Klonaris;Sotirios Georgopoulos;Theodoros Liakakos |
| Journal | diogenes |
| Year | 2016 |
| DOI |
10.1155/2016/3121469
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.